Organisation
Rehabilitation Sciences, Bruges Campus
Research Unit
Research is aimed at understanding movement deficits as well as the human rehabilitation potential and ability to prevent further morbidity.
Current researchers
11 - 16 of 16 results
- Mari Naaris (Member)
- Rik Provoost (Member)
- Stijn Rosseel (Member)
- Tamaya Van Criekinge (Member)
- Ellen Van Wonterghem (Member)
- Inti Vanmechelen (Member)
Projects
11 - 20 of 30
- Automated VIdeo-based assessment of DYSkinesia in cerebral palsy using markerless pose estimation and machine learning (AVI-DYS)From1 Nov 2021 → 31 Oct 2023Funding: FWO fellowships
- Effectiveness of different foot orthotic designs on the foot kinematics and plantar loading of patients with hallux limitusFrom28 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Contribution of the intrinsic foot muscles toward the receptive and propulsive behaviour of the foot joints.From1 Sep 2021 → TodayFunding: BOF - doctoral mandates
- Wheelchair skills training for people with complex movement disorderFrom15 Mar 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- m-MALL: moving towards the next generation motion analysis researchFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- A Framework for Real-Time Difficulty Adaptation of Interactive Systems for RehabilitationFrom21 Oct 2020 → 31 Dec 2022Funding: FWO fellowships
- Adaptive Rehabilitative Gaming Systems for Powered Mobility Training in People with Complex Movement Disorders (ADA Games)From1 Oct 2020 → TodayFunding: BOF - projects
- Dose-response effect of computer-aided design foot orthoses on foot and lower limb biomechanics of patients with patellofemoral pain.From12 Jun 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Inverse Kinematic Alignment for Total Knee Arthroplasty The Concept, Clinical Outcomes and Biomechanical OutcomesFrom27 Jan 2020 → 6 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Eyes on communication a novel intervention and research approach for children with cerebral palsy using eye-gaze technology(PG13918)From1 Jan 2020 → 31 Dec 2021Funding: Foreign private sponsor - undefined
Publications
1 - 10 of 334
- Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus (vol 118, pg 7, 2018)(2018)
Authors: Catherine Lambert, Bénédicte Dubois, Dominique Dive, Andreas Lysandropoulos, Dominik Selleslag, Ludo Vanopdenbosch, Vincent Van Pesch, Bart Vanwijmeersch, Ann Janssens
Pages: 141 - 141 - Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential(2018)
Authors: Alexander Klistorner, Yi Chai, Letizia Leocani, Philipp Albrecht, Orhan Aktas, Helmut Butzkueven, Tjalf Ziemssen, Focke Ziemssen, Jette Frederiksen, Lei Xu, et al.
Pages: 1159 - 1171 - De waarde van de CELF-4NL in diagnostiek na gebruik van testmodificaties bij successief tweetalige kinderen tussen 5;0 - 5;5 jaar uit West-Vlaanderen(2013)
Authors: Jan Deklerck
Pages: 26 - 40 - The PEARL study protocol: a pan-european prospective observational study of fremanezumab effectiveness in patients with chronic or episodic migraine in the real world(2020)
Authors: Marco Konings
Pages: 607 - 607 - P 110 - Lower limb muscle volume estimation from maximum cross-sectional area and muscle length in cerebral palsy and typically developing individuals.(2018)
Authors: Inti Vanmechelen, A Shortland, J Noble
Pages: 418 - 420 - Quantification of skin marker movement at the malleoli and talar head(2010)
Authors: Ivan Birch, Kevin Deschamps
Pages: 497 - 504 - Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial(2017)
Authors: Diego Cadavid, Laura Balcer, Steven Galetta, Orhan Aktas, Tjalf Ziemssen, Ludo Vanopdenbosch, Jette Frederiksen, Mark Skeen, Glenn J Jaffe, Helmut Butzkueven, et al.
Pages: 189 - 199 - Palliative Care in Multiple Sclerosis.(2016)
Authors: Ludo Vanopdenbosch
Pages: 943 - 946 - Safety of shorter ocrelizumab infusion confirmed over multiple administrations: results of the ENSEMBLE PLUS substudy(2022)
Authors: Ludo Vanopdenbosch
Pages: 647 - 649 - Efficacy for remyelination and safety of anti-lingo-1 monoclonal antibody (biib033) in acute optic neuritis: results from the renew study(2015)
Authors: Ludo Vanopdenbosch
Pages: E14 - E15